• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗症状评估量表(C-SAS)的开发:一种用于对接受细胞毒性化疗患者的症状体验进行常规临床评估的量表。

The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy.

作者信息

Brown V, Sitzia J, Richardson A, Hughes J, Hannon H, Oakley C

机构信息

Research and Development Department, Worthing and Southlands Hospitals NHS Trust, Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK.

出版信息

Int J Nurs Stud. 2001 Oct;38(5):497-510. doi: 10.1016/s0020-7489(00)00106-1.

DOI:10.1016/s0020-7489(00)00106-1
PMID:11524097
Abstract

The management of symptoms experienced by patients receiving cytotoxic chemotherapy influences quality of life during treatment. Symptom management may be improved through a structured approach to symptom assessment. This paper describes the development of the Chemotherapy Symptom Assessment Scale (C-SAS), a 24-item scale designed for the routine assessment of symptoms experienced by patients receiving cytotoxic chemotherapy. The scale development process focused both upon the psychometric properties and the clinical usefulness of the scale. Patients and health professionals played a significant role in item selection and scale design in order to maximise the clinical utility of the C-SAS.

摘要

接受细胞毒性化疗的患者所经历症状的管理会影响治疗期间的生活质量。通过结构化的症状评估方法可改善症状管理。本文描述了化疗症状评估量表(C-SAS)的开发过程,这是一个包含24个条目的量表,旨在对接受细胞毒性化疗的患者所经历的症状进行常规评估。量表开发过程既注重量表的心理测量特性,也注重其临床实用性。患者和卫生专业人员在条目选择和量表设计中发挥了重要作用,以最大限度地提高C-SAS的临床效用。

相似文献

1
The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy.化疗症状评估量表(C-SAS)的开发:一种用于对接受细胞毒性化疗患者的症状体验进行常规临床评估的量表。
Int J Nurs Stud. 2001 Oct;38(5):497-510. doi: 10.1016/s0020-7489(00)00106-1.
2
Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey.Nightingale 症状评估量表(N-SAS)的制定和验证及土耳其癌症患者生活质量的预测因素。
Eur J Oncol Nurs. 2011 Feb;15(1):3-11. doi: 10.1016/j.ejon.2009.10.010. Epub 2009 Nov 26.
3
Benefits of using a chemotherapy symptom assessment scale.
Nurs Times. 2003;99(39):50-1.
4
WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.WISECARE+:一项关于化疗相关症状管理护理干预的欧洲研究结果。
Eur J Oncol Nurs. 2008 Dec;12(5):443-8. doi: 10.1016/j.ejon.2008.07.005. Epub 2008 Oct 7.
5
Treatment type and symptom severity among oncology patients by self-report.
Int J Nurs Stud. 2001 Jun;38(3):359-67. doi: 10.1016/s0020-7489(00)00067-5.
6
Chemotherapy-induced nausea and vomiting (CINV): detection and management of postinfusion CINV--how are we doing?化疗引起的恶心和呕吐(CINV):输注后CINV的检测与管理——我们做得如何?
ONS News. 2006;21(8 Suppl):43-4.
7
The Patient Care Monitor-Neutropenia Index: development, reliability, and validity of a measure for chemotherapy-induced neutropenia.患者护理监测器-中性粒细胞减少指数:一种化疗引起的中性粒细胞减少症测量方法的开发、可靠性和有效性
Oncol Nurs Forum. 2011 May;38(3):360-7. doi: 10.1188/11.ONF.360-367.
8
The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.一种改良的总神经病变评分(减少了神经病变疼痛严重程度项目)在用于测量接受紫杉烷类和铂类药物治疗患者的化疗引起的周围神经病变时的可靠性和有效性。
Cancer Nurs. 2010 May-Jun;33(3):173-83. doi: 10.1097/NCC.0b013e3181c989a3.
9
Use of a modified ESAS in cancer patients: a pilot study of patient and staff experiences.改良版电子症状评估系统在癌症患者中的应用:一项关于患者及医护人员体验的试点研究
Int J Palliat Nurs. 2007 Dec;13(12):610-6. doi: 10.12968/ijpn.2007.13.12.27890.
10
Symptom assessment of patients with advanced cancer and AIDS and their family caregivers: the results of a quality-of-life pilot study.晚期癌症和艾滋病患者及其家庭护理人员的症状评估:一项生活质量试点研究的结果。
Am J Hosp Palliat Care. 2007 Oct-Nov;24(5):350-65. doi: 10.1177/1049909106299063.

引用本文的文献

1
Development of Integrated Supportive Care Nursing Competence Scale for Cancer Survivors.癌症幸存者综合支持性护理护理能力量表的编制
Healthcare (Basel). 2024 Mar 30;12(7):755. doi: 10.3390/healthcare12070755.
2
Evaluating a shared care pathway intervention for people receiving chemotherapy to reduce post-treatment unplanned hospital presentations: a randomised controlled trial.评估针对接受化疗的人群的共同照护路径干预措施,以减少治疗后非计划性医院就诊:一项随机对照试验。
Support Care Cancer. 2024 Jan 3;32(1):77. doi: 10.1007/s00520-023-08261-w.
3
The Effect of Family-Centered Supportive Program on Chemotherapy-Induced Symptoms in Patients with Acute Lymphoblastic Leukemia (ALL).
以家庭为中心的支持项目对急性淋巴细胞白血病(ALL)患者化疗所致症状的影响
Int J Hematol Oncol Stem Cell Res. 2021 Jan 1;15(1):35-50. doi: 10.18502/ijhoscr.v15i1.5248.
4
Evaluation of the Efficacy of the Three-Component Health Care Management Program HEWCOT in Colorectal Cancer Patients Receiving Chemotherapy.三成分医疗保健管理项目HEWCOT对接受化疗的结直肠癌患者的疗效评估
J Cancer Educ. 2020 Apr;35(2):274-283. doi: 10.1007/s13187-018-1461-2.
5
Effectiveness of Internet-based interventions in managing chemotherapy-related symptoms in patients with cancer: a systematic literature review.基于互联网的干预措施在管理癌症患者化疗相关症状中的有效性:系统文献回顾。
Support Care Cancer. 2018 Feb;26(2):361-374. doi: 10.1007/s00520-017-3900-8. Epub 2017 Sep 25.
6
The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.eSMART研究方案:一项随机对照试验,旨在评估使用先进症状管理系统(ASyMS)远程技术对癌症患者进行电子症状管理。
BMJ Open. 2017 Jun 6;7(5):e015016. doi: 10.1136/bmjopen-2016-015016.
7
The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial.患者远程干预与症状管理系统(PRISMS)——一种通过远程医疗进行的干预措施,可对血液系统恶性肿瘤患者的化疗副作用进行实时监测:一项随机对照试验的研究方案
Trials. 2015 Oct 19;16:472. doi: 10.1186/s13063-015-0970-0.
8
The psychometric properties of cancer multisymptom assessment instruments: a clinical review.癌症多症状评估工具的心理测量特性:一项临床综述。
Support Care Cancer. 2015 Jul;23(7):2189-202. doi: 10.1007/s00520-015-2732-7. Epub 2015 Apr 19.
9
Effect on Symptom Management Education Receiving Patients of Chemotherapy.化疗对接受症状管理教育患者的影响。
J Cancer Educ. 2016 Mar;31(1):101-7. doi: 10.1007/s13187-015-0801-8.
10
Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.患者报告的药物不良事件问卷的开发与初步验证
Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8.